148
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease

, , , , &
Pages 2433-2443 | Published online: 16 Aug 2017

References

  • FreixaXPortilloKParéCEchocardiographic abnormalities in patients with COPD at their first hospital admissionEur Respir J201341478479123018914
  • BellocchiaMMasoeroMCiuffredaAPredictors of cardiovascular disease in asthma and chronic obstructive pulmonary diseaseMultidiscip Respir Med2013815824004921
  • ChaouatANaeijeRWeitzenblumEPulmonary hypertension in COPDEur Respir J20083251371138518978137
  • LeeJHChangJHLung function in patients with chronic airflow obstruction due to tuberculous destroyed lungRespir Med200397111237124214635980
  • KimSJLeeJParkYSEffect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosisJ Korean Med Sci201530673774226028926
  • SeoYKLeeCHLeeH-KDifferences between patients with TB-destroyed lung and patients with COPD admitted to the ICUTuberculosis and Respiratory Diseases2011704323329
  • RyuYJLeeJHChunEMChangJHShimSSClinical outcomes and prognostic factors in patients with tuberculous destroyed lungInt J Tuberc Lung Dis201115224625021219689
  • WrobelJPThompsonBRWilliamsTJMechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic reviewJ Heart Lung Transplant201231655756422502811
  • SommerNDietrichASchermulyRRegulation of hypoxic pulmonary vasoconstriction: basic mechanismsEur Respir J20083261639165119043010
  • DhedaKBoothHHuggettJFJohnsonMAZumlaARookGALung remodeling in pulmonary tuberculosisJ Infect Dis200519271201120916136463
  • KimHYSongKSGooJMLeeJSLeeKSLimTHThoracic sequelae and complications of tuberculosisRadiographics200121483985811452057
  • VoelkelNFMizunoSBogaardHJThe role of hypoxia in pulmonary vascular diseases: a perspectiveAm J Physiol Lung Cell Mol Physiol20133047L457L46523377344
  • SteinerMKSyrkinaOLKolliputiNMarkEJHalesCAWaxmanABInterleukin-6 overexpression induces pulmonary hypertensionCirc Res2009104223624419074475
  • ZangiabadiADe PasqualeCGSajkovDPulmonary hypertension and right heart dysfunction in chronic lung diseaseBiomed Res Int2014201473967425165714
  • HurdmanJCondliffeRElliotCAPulmonary hypertension in COPD: results from the ASPIRE registryEur Respir J20134161292130123018917
  • KyungSYKimYJAnCHLeeSPParkJWJeongSHClinical findings of the patients with legal pulmonary disability – short-term follow-up at a tertiary university hospital in KoreaKorean J Intern Med2008232727718646509
  • HongSBOhBJKimYSCharacteristics of mechanical ventilation employed in intensive care units: a multicenter survey of hospitalsJ Korean Med Sci200823694895319119434
  • StenmarkKRFaganKAFridMGHypoxia-induced pulmonary vascular remodeling cellular and molecular mechanismsCirc Res200699767569117008597
  • MenezesAMHallalPCPerez-PadillaRTuberculosis and airflow obstruction: evidence from the PLATINO study in Latin AmericaEur Respir J20073061180118517804445
  • D’AltoMRomeoEArgientoPAccuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertensionInt J Cardiol201316844058406223890907
  • RudskiLGLaiWWAfilaloJGuidelines for the echocar-diographic assessment of the right heart in adults: a report from the American Society of Echocardiography: endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of EchocardiographyJ Am Soc Echocardiogr201023768571320620859
  • EvangelistaAFlachskampfFLancellottiPEuropean Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studiesEur J Echocardiogr20089443844818579482
  • CutticaMJKalhanRShlobinOACategorization and impact of pulmonary hypertension in patients with advanced COPDRespir Med2010104121877188220547449
  • LeuchteHHBaumgartnerRANounouMEBrain natriuretic peptide is a prognostic parameter in chronic lung diseaseAm J Respir Crit Care Med2006173774475016415273
  • AndersenCUMellemkjærSNielsen-KudskJEEchocardiographic screening for pulmonary hypertension in stable COPD outpatients and NT-proBNP as a rule-out testCOPD20129550551222708731
  • World Health OrganizationGlobal tuberculosis report 20162016 Available from: http://www.who.int/tb/publications/global_report/en/Accessed July 20, 2017
  • ElwingJPanosRJPulmonary hypertension associated with COPDInt J Chron Obstruct Pulmon Dis200831557018488429
  • EhrlichRIAdamsSBaatjiesRJeebhayMFChronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studiesInt J Tuberc Lung Dis201115788689121477424
  • JordanTSSpencerEMDaviesPTuberculosis, bronchiectasis and chronic airflow obstructionRespirology201015462362820409028
  • VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
  • AlatasFAlatasOMetintasMOzarslanAErginelSYildirimHVascular endothelial growth factor levels in active pulmonary tuberculosisChest200412562156215915189936
  • RheeCKYooKHLeeJHClinical characteristics of patients with tuberculosis-destroyed lungInt J Tuberc Lung Dis2013171677523232006
  • KesslerRFallerMWeitzenblumE“Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung diseaseAm J Respir Crit Care Med2001164221922411463591